Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $24.2400 (1.66%) ($23.6300 - $24.3900) on Thu. Aug. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.94% (three month average) | RSI | 65 | Latest Price | $24.2400(1.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.3% a day on average for past five trading days. | Weekly Trend | TGTX advances 9.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(64%) ARKG(59%) IWO(57%) ARKK(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -1.97% in a week (0% probabilities). VIXM(-36%) VXX(-33%) UUP(-18%) IGOV(-4%) DRIV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.97% (StdDev 3.94%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $23.7(2.28%) | 10 Day Moving Average | $23.33(3.9%) | 20 Day Moving Average | $21.74(11.5%) | To recent high | 0% | To recent low | 44.3% | Market Cap | $3.07b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |